Cutting edge: Inhibitory effects of CD4 and CD8 on T cell activation induced by high-affinity noncognate ligands

Journal of Immunology

Volumn 183, Issue 12, 2009, Pages 7639-7643

  Chervin, Adam S ^a   Stone, Jennifer D ^a   Bowerman, Natalie A ^a   Kranz, David M ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN KINASE LCK; T LYMPHOCYTE RECEPTOR; CD4 ANTIGEN; CD8 ANTIGEN; H 2KB PROTEIN, MOUSE; H-2KB PROTEIN, MOUSE; H2 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; LIGAND; LYMPHOCYTE ANTIGEN RECEPTOR;

ARTICLE; BINDING AFFINITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CROSS REACTION; HYBRIDOMA; INHIBITION KINETICS; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; T LYMPHOCYTE ACTIVATION; ANIMAL; ANTIGEN PRESENTATION; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; DRUG ANTAGONISM; ENZYMOLOGY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; PHYSIOLOGY; PROTEIN BINDING; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD4; ANTIGENS, CD8; CELLS, CULTURED; H-2 ANTIGENS; HYBRIDOMAS; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; LIGANDS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); MICE; MICE, INBRED C57BL; PROTEIN BINDING; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTE SUBSETS;

EID: 76249103113     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901664     Document Type: Article

References (28)

1. Davis, M. M., J. J. Boniface, Z. Reich, D. Lyons, J. Hampl, B. Arden, and Y. Chien. 1998. Ligand recognition by αβT cell receptors. Annu. Rev. Immunol. 16: 523-544.
2. van der Merwe, P. A., and S. J. Davis. 2003. Molecular interactions mediating T cell antigen recognition. Annu. Rev. Immunol. 21: 659-684.
3. Anikeeva, N., T. Lebedeva, A. R. Clapp, E. R. Goldman, M. L. Dustin, H. Mattoussi, and Y. Sykulev. 2006. Quantum dot/peptide-MHC biosensors reveal strong CD8-dependent cooperation between self and viral antigens that augment the T cell response. Proc. Natl. Acad. Sci. USA 103: 16846-16851.
4. Norment, A. M., R. D. Salter, P. Parham, V. H. Engelhard, and D. R. Littman. 1988. Cell-cell adhesion mediated by CD8 and MHC class I molecules. Nature 336: 79-81.
5. Veillette, A., M. A. Bookman, E. M. Horak, L. E. Samelson, and J. B. Bolen. 1989. Signal transduction through the CD4 receptor involves the activation of the internal membrane tyrosine-protein kinase p56lck. Nature 338: 257-259. (Pubitemid 19086927)
6. Singer, A., S. Adoro, and J. H. Park. 2008. Lineage fate and intense debate: myths, models and mechanisms of CD4- versus CD8-lineage choice. Nat. Rev. Immunol. 8: 788-801.
7. Van Laethem, F., S. D. Sarafova, J. H. Park, X. Tai, L. Pobezinsky, T. I. Guinter, S. Adoro, A. Adams, S. O. Sharrow, L. Feigenbaum, and A. Singer. 2007. Deletion of CD4 and CD8 coreceptors permits generation of αβT cells that recognize antigens independently of the MHC. Immunity 27: 735-750. (Pubitemid 350102257)
8. H is sufficient for most antibody specificities. Immunity 13: 37-45.
9. Chervin, A. S., J. D. Stone, P. D. Holler, A. Bai, J. Chen, H. N. Eisen, and D. M. Kranz. 2009. The impact of TCR-binding properties and antigen presentation format on T cell responsiveness. J. Immunol. 183: 1166-1178.
10. Haughn, L., S. Gratton, L. Caron, R. P. Sekaly, A. Veillette, and M. Julius. 1992. Association of tyrosine kinase p56lck with CD4 inhibits the induction of growth through the α βT-cell receptor. Nature 358: 328-331.
11. Holler, P. D., and D. M. Kranz. 2003. Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation. Immunity 18: 255-264.
12. Jones, L. L., S. E. Brophy, A. J. Bankovich, L. A. Colf, N. A. Hanick, K. C. Garcia, and D. M. Kranz. 2006. Engineering and characterization of a stabilized α1/α2 module of the class I major histocompatibility complex product Ld. J. Biol. Chem. 281: 25734-25744.
13. Letourneur, F., and B. Malissen. 1989. Derivation of a T cell hybridoma variant deprived of functional T cell receptor αand βchain transcripts reveals a nonfunctional α-mRNA of BW5147 origin. Eur. J. Immunol. 19: 2269-2274. (Pubitemid 20024752)
14. Stone, J. D., A. S. Chervin, and D. M. Kranz. 2009. T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity. Immunology 126: 165-176.
15. Feinerman, O., J. Veiga, J. R. Dorfman, R. N. Germain, and G. Altan-Bonnet. 2008. Variability and robustness in T cell activation from regulated heterogeneity in protein levels. Science 321: 1081-1084.
16. Palmer, E., and D. Naeher. 2009. Affinity threshold for thymic selection through a T-cell receptor-co-receptor zipper. Nat. Rev. Immunol. 9: 207-213.
17. Hoo, W. S., and D. M. Kranz. 1993. Role of CD8 in staphylococcal enterotoxin B-mediated lysis by cytotoxic T lymphocytes. J. Immunol. 150: 4331-4337.
18. Wooldridge, L., S. L. Hutchinson, E. M. Choi, A. Lissina, E. Jones, F. Mirza, P. R. Dunbar, D. A. Price, V. Cerundolo, and A. K. Sewell. 2003. Anti-CD8 antibodies can inhibit or enhance peptide-MHC class I (pMHCI) multimer binding: this is paralleled by their effects on CTL activation and occurs in the absence of an interaction between pMHCI and CD8 on the cell surface. J. Immunol. 171: 6650-6660.
19. Daniels, M. A., and S. C. Jameson. 2000. Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers. J. Exp. Med. 191: 335-346.
20. Devine, L., M. E. Hodsdon, M. A. Daniels, S. C. Jameson, and P. B. Kavathas. 2004. Location of the epitope for an anti-CD8α antibody 53.6.7 which enhances CD8α- MHCclass I interaction indicates antibody stabilization of a higher affinity CD8 conformation. Immunol. Lett. 93: 123-130. (Pubitemid 38670364)
21. + thymocytes by p56lck tyrosine kinase: basis for differential signaling by CD4 and CD8 in immature thymocytes expressing both coreceptor molecules. J. Exp. Med. 178: 1701-1712.
22. Teh, H. S., H. Kishi, B. Scott, and H. Von Boehmer. 1989. Deletion of autospecific T cells in T cell receptor (TCR) transgenic mice spares cells with normal TCR levels and low levels of CD8 molecules. J. Exp. Med. 169: 795-806.
23. Robey, E. A., F. Ramsdell, D. Kioussis, W. Sha, D. Loh, R. Axel, and B. J. Fowlkes. 1992. The level of CD8 expression can determine the outcome of thymic selection. Cell 69: 1089-1096.
24. Lee, N. A., D. Y. Loh, and E. Lacy. 1992. CD8 surface levels alter the fate of α/βT cell receptor-expressing thymocytes in transgenic mice. J. Exp. Med. 175: 1013-1025.
25. Jones, L. L., L. A. Colf, J. D. Stone, K. C. Garcia, and D. M. Kranz. 2008. Distinct CDR3 conformations in TCRs determine the level of cross-reactivity for diverse antigens, but not the docking orientation. J. Immunol. 181: 6255-6264.
26. Sykulev, Y., A. Brunmark, T. J. Tsomides, S. Kageyama, M. Jackson, P. A. Peterson, and H. N. Eisen. 1994. High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins. Proc. Natl. Acad. Sci. USA 91: 11487-11491. (Pubitemid 24356369)
27. Arsov, I., and S. Vukmanovic. 1999. Dual MHC class I and class II restriction of a single T cell receptor: distinct modes of tolerance induction by two classes of autoantigens. J. Immunol. 162: 2008-2015. (Pubitemid 29288819)
28. + T cells expressing a nominally MHC class I-restricted T cell receptor by two different mechanisms. Proc. Natl. Acad. Sci. USA 103: 1822-1827.